I did not follow my rules except one and that was the catalyst: the company was approved by the FDA to begin phase one trials for its PYX 106/201 from the U.S. Food and Drug Administration. I made daily watchlists last month without trading and seeing where each one that received FDA approval went R2G for days. My though process was the exact same for PYXS. Even Tim said "CUT YOUR LOSSES"